Ectopic expression of active processed form of atrial natriuretic peptide in skeletal myoblasts

被引:2
作者
Byun, J
Kim, SH
Kim, SZ
Heard, JM
Huh, JE
Choe, YH
Park, SJ
Jung, EA
Kim, DK
机构
[1] Sungkyunkwan Univ, Sch Med, Ctr Clin Res,Samsung Biomed Res Inst, Cardiovasc Inst,Samsung Med Ctr, Seoul 135710, South Korea
[2] Jeonbug Natl Univ, Sch Med, Dept Physiol, Jeonju, South Korea
[3] Inst Pasteur, Lab Retrovirus & Transfert Genet, F-75724 Paris, France
关键词
ANP; ectopic expression; processing; cGMP; myoblast; gene therapy;
D O I
10.1006/bbrc.2000.2468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atrial natriuretic peptide (ANP) is a cardiac hormone that elicits a profound diuresis, natriuresis, and hypotension. As a preliminary study toward ANP gene therapy of cardiovascular disorders, we have cloned a cDNA for mouse preproANP and carried out expression studies in muscle cells, The expression cassette, which was flanked by ITRs from AAV-8, consisted of HCMV IE enhancer/promoter, preproANP gene, and polyadenylation signal from bovine growth hormone. We transfected this expression vector into primary skeletal myoblasts and examined the following points: (1) secretion of immunoreactive ANP, (2) biological activity, and (3) nature of secreted ANP(s). The conditioned media from cells transfected with ANP vector had significantly higher levels of irANP in comparison to mock control. The secreted irANP had biological activity as confirmed by the elevated level of intracellular cGMP in human umbilical vein endothelial cells. Reverse-phase HPLC analysis showed that the processed form of ANP was the predominant form. These results demonstrate that preproANP gene could be ectopically expressed and correctly processed in skeletal myoblasts, which has implications for development of muscle-based ANP gene therapy. (C) 2000 Academic Press.
引用
收藏
页码:637 / 642
页数:6
相关论文
共 39 条
  • [1] SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS
    BARR, E
    LEIDEN, JM
    [J]. SCIENCE, 1991, 254 (5037) : 1507 - 1509
  • [2] MUSCLE-MEDIATED GENE-THERAPY
    BLAU, HM
    SPRINGER, ML
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) : 1554 - 1556
  • [3] DIVERSE BIOLOGICAL ACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE
    BRENNER, BM
    BALLERMANN, BJ
    GUNNING, ME
    ZEIDEL, ML
    [J]. PHYSIOLOGICAL REVIEWS, 1990, 70 (03) : 665 - 699
  • [4] ATRIAL NATRIURETIC PEPTIDE - BLOOD-LEVELS IN HUMAN-DISEASE AND THEIR MEASUREMENT
    CERNACEK, P
    CRAWHALL, JC
    LEVY, M
    [J]. CLINICAL BIOCHEMISTRY, 1988, 21 (01) : 5 - 17
  • [5] ATRIAL PRESSURE, DISTENSION, AND PACING FREQUENCY IN ANP SECRETION IN ISOLATED PERFUSED RABBIT ATRIA
    CHO, KW
    SEUL, KH
    KIM, SH
    SEUL, KM
    KOH, GY
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01): : R39 - R46
  • [6] Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle
    Clark, KR
    Sferra, TJ
    Johnson, PR
    [J]. HUMAN GENE THERAPY, 1997, 8 (06) : 659 - 669
  • [7] PROLONGED LOW-DOSE INFUSION OF ATRIAL NATRIURETIC FACTOR IN ESSENTIAL-HYPERTENSION
    CUSSON, JR
    THIBAULT, G
    CANTIN, M
    LAROCHELLE, P
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1990, 12 (01) : 111 - 135
  • [8] Davis H L, 1995, Mol Cell Biol Hum Dis Ser, V5, P368
  • [9] SYSTEMIC DELIVERY OF HUMAN GROWTH-HORMONE BY INJECTION OF GENETICALLY ENGINEERED MYOBLASTS
    DHAWAN, J
    PAN, LC
    PAVLATH, GK
    TRAVIS, MA
    LANCTOT, AM
    BLAU, HM
    [J]. SCIENCE, 1991, 254 (5037) : 1509 - 1512
  • [10] Viral sequences enable efficient and tissue-specific expression of transgenes in Xenopus
    Fu, YC
    Wang, YB
    Evans, SM
    [J]. NATURE BIOTECHNOLOGY, 1998, 16 (03) : 253 - 257